In addition, decreased gene expression of NRG1 and dystrobrevin binding protein 1 (DTNBP1) were shown to be lower in immortalized lymphocytes from patients with schizophrenia vs. controls before and after treatment with the antipsychotic olanzapine (Chagnon et al., 2008). The gene discussed is NRG1; the disease is schizophrenia.